
Coeptis Therapeutics Holdings Inc. Common Stock
COEP
COEP: Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio comprises multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
moreShow COEP Financials
Recent trades of COEP by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by COEP's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on COEP's company Twitter account
Number of mentions of COEP in WallStreetBets Daily Discussion
Recent insights relating to COEP
Recent picks made for COEP stock on CNBC
ETFs with the largest estimated holdings in COEP
Flights by private jets registered to COEP